iShares Biotechnology ETF
897 hedge funds and large institutions have $5.97B invested in iShares Biotechnology ETF in 2022 Q4 according to their latest regulatory filings, with 139 funds opening new positions, 257 increasing their positions, 288 reducing their positions, and 44 closing their positions.
Holders
897
Holders Change
+73
Holders Change %
+8.86%
% of All Funds
14.47%
Holding in Top 10
22
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+57.14%
% of All Funds
0.35%
New
139
Increased
257
Reduced
288
Closed
44
Calls
$325M
Puts
$511M
Net Calls
-$186M
Net Calls Change
+$278M
